Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing the safety and the effect of food on the single-dose bioavailability of F-02-2-Na in healthy adult subjects. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • F-02-2-Na (F-02-2-Na)

Snippet

Sponsor: Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd. | Conditions: Hyperuricemia With or Without Gout | Phase 1 | Status: NOT_YET_RECRUITING